In the world of mergers and acquisitions, healthcare stands among the titans. In hospital systems, mega pharmaceuticals, and medical device manufacturers, the price of entry is stratospheric, and operations are complex and intertwined. But the rewards are massive. In 2018, American healthcare spending was up 4.6% to $3.6 trillion. At more than $11,000 per person, health spending accounts for nearly 18% of the country’s gross domestic product (GDP).
It’s little wonder the general and specialty provider sectors are leaders in the M&A space. With transactions often measured in billions, these deals involve multiple investment banks, potentially thousands of people hammering out the deals, and often publicly traded companies.